Longevity Health Holdings, Inc. (NASDAQ:XAGE – Get Free Report)’s share price traded down 11.9% on Monday . The company traded as low as $0.21 and last traded at $0.28. Approximately 598 shares changed hands during trading, a decline of 77% from the average daily volume of 2,557 shares. The stock had previously closed at $0.3180.
Longevity Health Trading Down 19.6%
The company has a market cap of $400,950.00, a PE ratio of -0.05 and a beta of 0.40. The business has a fifty day moving average of $0.26 and a 200-day moving average of $0.30.
Longevity Health Company Profile
Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.
Further Reading
- Five stocks we like better than Longevity Health
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Longevity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Longevity Health and related companies with MarketBeat.com's FREE daily email newsletter.
